Background: Elevated high sensitivity C-reactive protein (hs-CRP) has been well known as a biomarker reflecting inflammatory process for prediction of ischemic events among patients with coronary artery disease. Relatively small studies have identified a heightened and sustained inflammatory response after percutaneous coronary intervention (PCI) to be a predictor of periprocedural events after coronary angioplasty and a marker of increased restenosis risk among patients undergoing coronary stenting. Embolization of atherosclerotic and thrombotic debris can induce myocardial necrosis during PCI. This study was designed to evaluate whether pre procedural hs-CRP level is associated with procedure related distal microembolization producing myocardial injury (assessed by CK-MB level) after PCI. 
Introduction:
PCI has become one of the cardinal treatment strategies for stenotic coronary artery disease, over the past three decades.. Owing to improvement in interventional techniques and expertise as well as to the introduction of new devices such as stents, the incidence of major peri-procedural ischaemic complications (myocardial infarction, coronary artery bypass grafting, and cardiac death) was reduced from initially 9% to currently less than 2%. 1.2 However, the incidence of post-procedural cardiac marker elevation has not substantially declined since its first serial assessment by Oh et al. in 1985 . 3 These post-procedural cardiac marker elevations are considered to represent peri-procedural myocardial injury (PMI) with worse long-term outcome.
Since the last decade, systemic inflammatory markers have been carefully investigated; among these, several have been related to the risk of death, myocardial infarction, or restenosis after PCI, but only C-reactive protein (CRP) has been consistently shown to significantly and independently confer an adverse prognosis in patients with coronary artery disease, including those undergoing PCI. [4] [5] [6] This is probably because of its relatively long half-life and chemical stability as well as the limited costs and logistic hurdles faced by clinicians willing to measure it. 6 Increased C-reactive protein may become an important factor in pre-procedural risk stratification. As an independent marker for the rapid progression of atherosclerosis or the presence of an increased risk of subsequent adverse clinical outcome, increased C-reactive protein may identify high-risk patients as candidates for high dose lipid lowering therapy. 7 Cardiac biomarkers have been extensively used in the past two decades to establish the incidence and the prognostic implication of PMI. Elevation of both creatine kinase-myocardial band isoform (CK-MB) and cardiac troponin has been associated with a worse short and long-term outcome. [8] [9] [10] Although controversies regarding the prognostic significance of individual cardiac biomarkers persist, CK-MB elevation is widely accepted as a biomarker with prognostic significance when raised post-PCI. Elevation of CK-MB above the normal levels occurs in about 30% of patients undergoing elective PCI. 8 More than 60 studies in the past two decades have assessed the prognostic significance of elevations in total CK and/or CK-MB fraction following PCI. Metaanalyses evaluating the prognostic value of CK-MB release during PCI have inferred the proportionate increase in the early and late mortality with increased CK-MB release peri-procedurally. 11 Elevated high sensitivity C-reactive protein (hs-CRP) has been well known as a biomarker reflecting inflammatory process for prediction of ischemic events among patients with coronary artery disease. Relatively small studies have identified a heightened and sustained inflammatory response after PCI to be a predictor of periprocedural events after coronary angioplasty and a marker of increased restenosis risk among patients undergoing coronary stenting. Embolization of atherosclerotic and thrombotic debris can induce myocardial necrosis during PCIs. This study was designed to evaluate whether pre procedural hs-CRP level is associated with procedure related distal microembolization producing myocardial injury (assessed by CK-MB level) after PCIs.
Methods:
This prospective, observational study was conducted in the National Institute of Cardiovascular Disease (NICVD), Dhaka from January 2012 to December 2013 with a view to evaluate the relationship between preprocedural hs-CRP and rise of CK-MB level, before and after PCI. A total of 310 patients with chronic stable angina and unstable angina, who would undergo elective percutaneous coronary intervention were included and devided in 2 groups according to hs-CRP: Group I = hs-CRP <3 mg/ L, Group II = hs-CRP >3 mg/ L.
Laboratory Analysis:
Peripheral blood samples for measurement of baseline CK-MB and high sensitivity C-reactive protein was taken on the day before PCI. C-reactive protein was assayed by latex-enhanced immune nephelometry on a Behring BN-Pro Spec Nephelometer (SIEMENS, USA). CK-MB levels also being measured at 8 hours and 24 hours after the procedure. The definition of PMI included any increase of CKMB more than one time the upper limit of normal (ULN). Moreover, according to the universal definition of myocardial infarction, PCI-related myocardial infarction was defined only in case of an increase of CK-MB more than three times ULN, whereas elevations of cardiac biomarkers between one and three times ULN were considered as indicative of periprocedural myocardial necrosis, but not infarction. 12 Angiographic Analysis: Coronary angiographic findings were recorded before balloon dilatation and after stenting and interpretation was done by one interventional cardiologist using standard protocol. In this study angiographic severity of coronary artery disease was assessed by vessel score, stenosis score, lesion morphology and TIMI flow grading. Vessel score 13 : Score ranged from 0 to 4, depending on the number of vessels involved with a significant stenosis. (50% or greater luminal stenosis). Stenosis score 13 : The evaluation of degree of stenosis relates to the percentage reduction in the diameter of the vessel. By Gensini score, the lesions are roughly classified by visual estimation of reduction of luminal diameter.
Lesion morphology 14 : Type A, Type B and Type C lesion established by a joint ACC/AHA task force.
Culprit artery TIMI flow 14 : According to the TIMI grade flow in the culprit artery is defined by American College of Cardiology (TIMI Grade 0-3) Percutaneous coronary intervention with stenting was carried out in an artery having 70% stenosis. Procedures were performed using standard angioplasty techniques, all patients received 600 mg clopidogrel prior to PCI and 150 unit per kg body weight unfractionated heparin was used during the procedure in every patient. Angiographic success of PCI was defined as residual stenosis < 20%, determined by visual estimation and Thrombolysis in Myocardial Infarction grade 3. 15 Procedural success was defined as achievement of angiographic success without major clinical complications (e.g. death, MI, emergency coronary artery bypass surgery) during hospitalization. 15 
Statistical Analysis:
Continuous baseline variables with normal distribution were expressed as mean ± SD and were compared by ttest. Categorical variables were compared by Fisher exact test or chi-square test where appropriate. Multiple logistic regression analysis was performed to establish the independent predictive value of pre-procedural C-reactive protein in addition to other traditional prognostic risk factors (control of confounding). The statistical analysis was performed using the Statistical Package for Social Sciences software (SPSS). A p-value <0·05 was considered statistically significant.
Results:
A total of 310 patients with chronic stable angina and unstable angina, who would undergo elective percutaneous coronary intervention were included and devided in 2 groups according to hs-CRP: Group I = hs-CRP < 3 mg/ L included 131 patients (42%) and Group II = hs-CRP >3 mg/ L included 179 patients (58%). The mean (±SD) age of the patients was 51 ± 6.93 years and 53 ± 6.04 years in group I and group II respectively, no significant difference was found between two groups. Most of the patients were in 5th decade of life in both groups. Male sex predominated in both groups, malefemale ratio was 2.5-2.7:1 and no significant (p=0.55) difference was found between two groups.
Regarding risk factors, patients with high preprocedural hsCRP had highest percentage of smoking (62%),followed by diabetes mellitus (55%), hypertension (45%), dyslipidemia(36%), and family h/o premature coronary artery disease(11%). Similarly among patients with normal preprocedural hsCRP group, smokers were predominant (58%), followed by diabetes mellitus (52%) hypertension (42%), dyslipidemia (32%), and family history of premature coronary artery disease (9%). Cross tab analysis found no statistically significant differences between two groups (p>0.05). We included patients with chronic stable angina and unstable angina which was 46% and 54% respectively in group I and 48% and 52% respectively in group II. The difference was not significant statistically (p>.05). Mean preprocedural hsCRP was 6.1 ± 2.4 and 1.2 ± 0.7 respectively among the groups and the difference was significant statistically (p<0.05). Fig.-1,2,3) . Periprocedural MI was found in 12 (6.7%) patients in group II and 2(1.5%) in group I, and the difference was significant statistically (p = 0.04). Periprocedural myocardial necrosis was found in 7 (5.3%) patients in group I and 38(21.2%) in group II, and the difference was significant statistically (p = 0.01). (Table-IV (Table VI) .
Discussion:
This prospective, observational study was conducted in the Department of Cardiology, National Institute of Cardiovascular Disease (NICVD), Dhaka from January 2012 to December 2013. The main objective of the study was to evaluate the association of preprocedural hsCRP with periprocedural myocardial injury assessed by rise of CK-MB level, before and after PCI.
The mean (±SD) age of the patients was 51 ± 6.93 years and 53 ± 6.04years in group I and group II respectively, no significant difference was found between two groups. Most of the patients were in 5 th decade of life in both groups. In studies done by Herrman, et al. 16 and de Winter, et al. 17 , study population were more elderly than our population and incidence were more in 7th decade of life. This higher age range may be due to increased life expectancy in the western country. Male sex predominated in both groups. Male-female ratio was 2.5-2.7:1. No significant (p=0.55) difference was found regarding sex distribution between two groups which correlates to study done by Herrmann, et al. 16 and de Winter, et al. 17 also showed male predominance in their study population. Among two groups, female was more in group II than group I, though the difference was not significant statistically (p>.05).Chew, et al. 18 reported a higher prevalence of female gender in patients with elevated preprocedural hsCRP levels (>3 mg/L). The Dallas Heart Study 19 demonstrated higher CRP levels Regarding risk factors, patients with high preprocedural hsCRP had highest percentage of smoking (62%),followed by diabetes mellitus (55%), hypertension(45%), dyslipidemia(36%), and family h/o premature coronary artery disease(11%). Similarly patients with normal preprocedural hsCRP group smokers were predominant (58%), followed by diabetes mellitus (52%) hypertension (42%), dyslipidemia (32%), and family history of premature coronary artery disease (9%).Cross tab analysis found no statistically significant differences between two groups (p>0.05). This distribution of risk factors in relation to hsCRP was consistent with those found by Herrmann, et al. 16 and Chew, et al. 18 Visser, et al 20 mentioned in their study that, the higher body mass index (BMI) is associated with higher CRP concentrations, even among young adults aged 17 to 39 years. These findings suggest a state of low-grade systemic inflammation in overweight and obese persons. In this current series it was observed that the BMI was higher in group II than in group I, although difference was not significant statistically (p>0.05). A similar observation was made by Herrmann, et al 16 in their study.
In this study, we included patient with chronic stable angina and unstable angina which was 46% and 54% respectively in group I and 48% and 52% respectively in group II. The difference was not significant statistically (p>.05).This was consistent with the study done by Chew, et al. 18 . Herrmann, et al. 16 also found statistically insignificant difference between two groups as that of our study.
In this study, angiographic severity was assessed by vessel score, stenosis, lesion morphology and TIMI flow grading . 21 showed that, statin therapy reduced periprocedural MI most prominently in patients with elevated preprocedural CRP level. Saadeddin, et al. 22 reported that, preprocedural CRP elevation in 41% of 85 patients with stable angina and who undergoing PCI, and this was associated with a 2.27-fold higher risk of developing periprocedural myocardial injury. Although angiographic success was same in two groups (100%), procedural success was less in high hsCRP group 155(86.59%) than in normal hsCRP group 129(97.7%) which was statistically significant (p < 0.5). This was not consistent with study by Herrmann, et al. 16 , where there was high procedural success rate (95%) in high hs-CRP group. Use of statins, GPIIb/IIIa inhibitor, more use of drug eluting stents might have some impact for such outcome.
Multivariate logistic regression analysis was done among traditional predictors of PCI outcome advanced age (>50 years), female gender, diabetes mellitus, BMI, hypertension, smoking, dylipidaemia, type C lesion , and hsCRP. After removing the effects of the all other variables, hs-CRP was found as as independent predictors of periprocedural myocardial injury during PCI, assessed by CK-MB elevation with OR 1.57 and p=0.001.
In this study, we demonstrated that baseline levels of CRP predicted the incidence of periprocedural CKMB elevation following PCI. Furthermore, a graded association between the extent of myocardial injury and CRP levels was present. Finally, CRP levels predicted periprocedural injury following PCI independently thus suggesting that a favoring effect on distal microembolization may be the main mechanisms underlying this association. The most common mechanisms of myocardial injury during PCI are distal embolization and side branch occlusion. Other significant causes include dissection, thrombus, no reflow/slow flow, or coronary perforation. Recent progress has been made for the identification of two main PMI patterns as well as for preventive strategies. type 1 (proximal type), which is in proximity to the target lesion of PCI may be due to side branch occlusion and type 2 (distal type), which is in the perfusion territory of the treated coronary artery due to structural and functional microvascular obstructions. 23 50 to 75% of all the PMI is type 2 (distal type). The key factors which influence the incidence and magnitude of PMI could be broadly classified into patient factors, angiographic or lesion related factors, and procedural factors. Assessment of these factors prior to the intervention allows risk stratification for PMI. Patient factors implicated for higher incidence of PMI include older age, multi-vessel CAD, diffuse CAD, systemic atherosclerosis, pre-existing renal impairment, presence of anaemia, preprocedural C-reactive protein elevation, and pre-procedural raised white blood cell count. [24] [25] [26] [27] [28] [29] The plaque burden, number of lesions, presence of bifurcation lesions, tortuosity, and calcification are all likely to influence myocardial injury during PCI. 30 
